No pharmacokinetic interactions with doxorubicin were observed in studies. Being a monoclonal antibody,<unk>  is neither metabolised by cytochrome P450 liver enzymes nor transported by transmembrane pumps, and is thus not expected to interact relevantly with other drugs.
Olaratumab
Ustekinumab
Emapalumab
Evolocumab
Evinacumab
Dupilumab
Anifrolumab
Alirocumab